secwatch.observer — SEC 8-K summary
======================================

Issuer:     InMed Pharmaceuticals Inc. (INM)
CIK:        0001728328
Form:       8-K
Filed at:   2025-06-30T23:59:59+00:00
Accession:  0001213900-25-059673
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

InMed Pharma raises $5M in private placement of pre-funded warrants and options
-------------------------------------------------------------------------------

- Gross proceeds ~$5M from 1,952,363 pre-funded warrants ($0.0001 exercise) and 1,952,363 preferred investment options at $2.436/share.
- Amended 199,115 existing options (Oct 2023) from $16.60 to $2.436 per share for $0.125 each.
- Proceeds to fund pipeline development, BayMedica commercial sales, and working capital.
- H.C. Wainwright acted as placement agent; received 126,904 agent options at $3.2013/share.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1728328/000121390025059673/0001213900-25-059673-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1728328/000121390025059673/ea0247476-8k_inmed.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-059673

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer